KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) EBIT Margin (2020 - 2025)

Hims & Hers Health (HIMS) has disclosed EBIT Margin for 6 consecutive years, with 1.49% as the latest value for Q4 2025.

  • Quarterly EBIT Margin fell 238.0% to 1.49% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.5% through Dec 2025, up 31.0% year-over-year, with the annual reading at 4.5% for FY2025, 31.0% up from the prior year.
  • EBIT Margin hit 1.49% in Q4 2025 for Hims & Hers Health, down from 1.97% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 9.88% in Q1 2025 to a low of 92.54% in Q1 2021.
  • Historically, EBIT Margin has averaged 10.94% across 5 years, with a median of 4.11% in 2023.
  • Biggest five-year swings in EBIT Margin: plummeted -7185bps in 2021 and later soared 7584bps in 2022.
  • Year by year, EBIT Margin stood at 25.46% in 2021, then soared by 73bps to 6.94% in 2022, then surged by 98bps to 0.16% in 2023, then skyrocketed by 2483bps to 3.86% in 2024, then tumbled by -62bps to 1.49% in 2025.
  • Business Quant data shows EBIT Margin for HIMS at 1.49% in Q4 2025, 1.97% in Q3 2025, and 4.9% in Q2 2025.